Tousignant Jennifer
Chief Legal Officer
Tousignant Jennifer has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.
On the most recent filing, Tousignant Jennifer is listed as Chief Legal Officer at Viridian Therapeutics, Inc.\DE. Inside the rolling window, Tousignant Jennifer reported no open-market purchases and 2 open-market sales totaling $419K in VRDN. The largest disclosed transaction in the window is a sale of 14,212 VRDN shares on Aug 19, 2026, worth $348K.
Companies traded
Other insiders at VRDN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$419K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tousignant Jennifer made?
Tousignant Jennifer has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Tousignant Jennifer trade?
Tousignant Jennifer has filed SEC Form 4 disclosures for 1 company, including VRDN.
When was Tousignant Jennifer's most recent SEC Form 4 filing?
Tousignant Jennifer's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.
What is Tousignant Jennifer's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tousignant Jennifer is listed as Chief Legal Officer.
What is Tousignant Jennifer's total buy and sell value in the current window?
Inside the rolling retention window, Tousignant Jennifer bought $0 and sold $419K based on SEC Form 4 filings.
What was Tousignant Jennifer's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,212 VRDN shares on 2026-08-19, worth $348K, per SEC Form 4 filings.